Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
about
Activation of protein kinase C isoforms and its impact on diabetic complications.Mechanisms of disease: the oxidative stress theory of diabetic neuropathyC-peptide and diabetic neuropathy.Biochemical pathways for microvascular complications of diabetes mellitus.Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications.Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats.Ruboxistaurin: PKC-beta inhibition for complications of diabetes.Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.Mechanism of diabetic neuropathy: Where are we now and where to go?Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.Cerebrolysin improves sciatic nerve dysfunction in a mouse model of diabetic peripheral neuropathy.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.Association of myelinated primary afferents impairment with mechanical allodynia in diabetic peripheral neuropathy: an experimental study in rats.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.High glucose-induced inhibition of 2-deoxyglucose uptake is mediated by cAMP, protein kinase C, oxidative stress and mitogen-activated protein kinases in mouse embryonic stem cells.Central Regulation of Glucose Homeostasis.
P2860
Q33881442-547758DE-0729-4E1D-AD4F-EC327786A840Q34553052-851A6D5D-CA81-4FD2-91E7-DAD68FD09706Q35207611-D159824E-5F8E-4E1B-B705-BFC6729DDAA8Q35590990-7AB391CE-3A1B-476B-A5C9-1A9F24A86E00Q36109233-7C5B046E-A147-4B51-82B0-651E27075233Q36293649-5D74FC5E-D2B7-4DE5-A766-8E4AD70573C5Q36322082-A4E2DD6F-DA96-41AB-8724-0F6338D4FF77Q36943782-A23240E7-F882-46A2-9994-006189F3ED0DQ37636163-37C987B0-D017-4A5A-86EB-1E1B4A62D051Q37974944-9BAFDF25-DE7B-45E6-84A6-7D1408B55499Q38213041-A897C376-5225-4AFE-A9A0-835F18BB8F0BQ38671591-787E4308-AFEB-448F-8805-0BBA62181731Q38716687-A4C4BB2C-C0AE-4D91-B06D-063FF6C6AC23Q38798588-CA9E0439-81CB-4B84-98C3-A7A4326BD188Q42362780-E59EAAEA-1899-4404-B216-C77728A9EC04Q45072634-19F30BB7-E1DA-4208-A97D-93DC91B3C4DAQ46951093-AF81156D-5C05-4C89-B991-39EA334D12D0Q48249963-37BBDA31-5CC4-44EF-8771-718198868C65
P2860
Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@en
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@nl
type
label
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@en
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@nl
prefLabel
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@en
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@nl
P2860
P356
P1476
Effects of protein kinase Cbet ...... tial fatty acid dysmetabolism.
@en
P2093
Norman E Cameron
P2860
P304
P356
10.1002/DMRR.307
P577
2002-07-01T00:00:00Z